SPECTRONRX Trademark

Trademark Overview

On Wednesday, April 16, 2025, a trademark application was filed for SPECTRONRX with the United States Patent and Trademark Office. The USPTO has given the SPECTRONRX trademark a serial number of 99140367. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 16, 2025. This trademark is owned by Nukemed, Inc.. The SPECTRONRX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Treatment of materials by means of therapeutic and diagnostic development and engineering of pharmaceuticals
spectronrx

General Information

Serial Number99140367
Word MarkSPECTRONRX
Filing DateWednesday, April 16, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, April 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTreatment of materials by means of therapeutic and diagnostic development and engineering of pharmaceuticals
Description of MarkThe mark consists of The word Spectron followed immediately with a capital R and stylized x.

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, April 16, 2025
Primary Code040
First Use Anywhere DateWednesday, July 1, 2020
First Use In Commerce DateWednesday, July 1, 2020

Trademark Owner History

Party NameNukemed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Trademark Events

Event DateEvent Description
Wednesday, April 16, 2025NEW APPLICATION ENTERED
Wednesday, April 16, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

spectronrx development engineering pharmaceuticals diagnostic therapeutic materials means treatment